HER2 score 2+ is considered a borderline case requiring further tests, e.g., Fluorescence in Situ Hybridization (FISH) and Silver in Situ Hybridization (SISH), to determine whether the cancer is HER2-positive or HER2-negative. Here, ERBB2 is linked to cancer.